Translating the immediate effects of S-Ketamine using hippocampal subfield analysis in healthy subjects-results of a randomized controlled trial
Abstract Antidepressant doses of ketamine rapidly facilitate synaptic plasticity and modify neuronal function within prefrontal and hippocampal circuits. However, most studies have demonstrated these effects in animal models and translational studies in humans are scarce. A recent animal study showe...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-04-01
|
Series: | Translational Psychiatry |
Online Access: | https://doi.org/10.1038/s41398-021-01318-6 |
id |
doaj-dc4807d813a3499da37db0e0de137099 |
---|---|
record_format |
Article |
spelling |
doaj-dc4807d813a3499da37db0e0de1370992021-04-04T11:44:13ZengNature Publishing GroupTranslational Psychiatry2158-31882021-04-011111910.1038/s41398-021-01318-6Translating the immediate effects of S-Ketamine using hippocampal subfield analysis in healthy subjects-results of a randomized controlled trialAnna Höflich0Christoph Kraus1Ruth M. Pfeiffer2Rene Seiger3Dan Rujescu4Carlos A. Zarate5Siegfried Kasper6Dietmar Winkler7Rupert Lanzenberger8Department of Psychiatry and Psychotherapy, Medical University of ViennaDepartment of Psychiatry and Psychotherapy, Medical University of ViennaBiostatistics Branch, National Cancer Institute, National Institutes of HealthDepartment of Psychiatry and Psychotherapy, Medical University of ViennaDepartment of Psychiatry, Psychotherapy and Psychosomatics, Martin-Luther-University Halle-WittenbergExperimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of HealthDepartment of Psychiatry and Psychotherapy, Medical University of ViennaDepartment of Psychiatry and Psychotherapy, Medical University of ViennaDepartment of Psychiatry and Psychotherapy, Medical University of ViennaAbstract Antidepressant doses of ketamine rapidly facilitate synaptic plasticity and modify neuronal function within prefrontal and hippocampal circuits. However, most studies have demonstrated these effects in animal models and translational studies in humans are scarce. A recent animal study showed that ketamine restored dendritic spines in the hippocampal CA1 region within 1 h of administration. To translate these results to humans, this randomized, double-blind, placebo-controlled, crossover magnetic resonance imaging (MRI) study assessed ketamine’s rapid neuroplastic effects on hippocampal subfield measurements in healthy volunteers. S-Ketamine vs. placebo data were analyzed, and data were also grouped by brain-derived neurotrophic factor (BDNF) genotype. Linear mixed models showed that overall hippocampal subfield volumes were significantly larger (p = 0.009) post ketamine than post placebo (LS means difference=0.008, standard error=0.003). Post-hoc tests did not attribute effects to specific subfields (all p > 0.05). Trend-wise volumetric increases were observed within the left hippocampal CA1 region (p = 0.076), and trend-wise volumetric reductions were obtained in the right hippocampal—amygdaloid transition region (HATA) (p = 0.067). Neither genotype nor a genotype–drug interaction significantly affected the results (all p > 0.7). The study provides evidence that ketamine has short-term effects on hippocampal subfield volumes in humans. The results translate previous findings from animal models of depression showing that ketamine has pro-neuroplastic effects on hippocampal structures and underscore the importance of the hippocampus as a key region in ketamine’s mechanism of action.https://doi.org/10.1038/s41398-021-01318-6 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Anna Höflich Christoph Kraus Ruth M. Pfeiffer Rene Seiger Dan Rujescu Carlos A. Zarate Siegfried Kasper Dietmar Winkler Rupert Lanzenberger |
spellingShingle |
Anna Höflich Christoph Kraus Ruth M. Pfeiffer Rene Seiger Dan Rujescu Carlos A. Zarate Siegfried Kasper Dietmar Winkler Rupert Lanzenberger Translating the immediate effects of S-Ketamine using hippocampal subfield analysis in healthy subjects-results of a randomized controlled trial Translational Psychiatry |
author_facet |
Anna Höflich Christoph Kraus Ruth M. Pfeiffer Rene Seiger Dan Rujescu Carlos A. Zarate Siegfried Kasper Dietmar Winkler Rupert Lanzenberger |
author_sort |
Anna Höflich |
title |
Translating the immediate effects of S-Ketamine using hippocampal subfield analysis in healthy subjects-results of a randomized controlled trial |
title_short |
Translating the immediate effects of S-Ketamine using hippocampal subfield analysis in healthy subjects-results of a randomized controlled trial |
title_full |
Translating the immediate effects of S-Ketamine using hippocampal subfield analysis in healthy subjects-results of a randomized controlled trial |
title_fullStr |
Translating the immediate effects of S-Ketamine using hippocampal subfield analysis in healthy subjects-results of a randomized controlled trial |
title_full_unstemmed |
Translating the immediate effects of S-Ketamine using hippocampal subfield analysis in healthy subjects-results of a randomized controlled trial |
title_sort |
translating the immediate effects of s-ketamine using hippocampal subfield analysis in healthy subjects-results of a randomized controlled trial |
publisher |
Nature Publishing Group |
series |
Translational Psychiatry |
issn |
2158-3188 |
publishDate |
2021-04-01 |
description |
Abstract Antidepressant doses of ketamine rapidly facilitate synaptic plasticity and modify neuronal function within prefrontal and hippocampal circuits. However, most studies have demonstrated these effects in animal models and translational studies in humans are scarce. A recent animal study showed that ketamine restored dendritic spines in the hippocampal CA1 region within 1 h of administration. To translate these results to humans, this randomized, double-blind, placebo-controlled, crossover magnetic resonance imaging (MRI) study assessed ketamine’s rapid neuroplastic effects on hippocampal subfield measurements in healthy volunteers. S-Ketamine vs. placebo data were analyzed, and data were also grouped by brain-derived neurotrophic factor (BDNF) genotype. Linear mixed models showed that overall hippocampal subfield volumes were significantly larger (p = 0.009) post ketamine than post placebo (LS means difference=0.008, standard error=0.003). Post-hoc tests did not attribute effects to specific subfields (all p > 0.05). Trend-wise volumetric increases were observed within the left hippocampal CA1 region (p = 0.076), and trend-wise volumetric reductions were obtained in the right hippocampal—amygdaloid transition region (HATA) (p = 0.067). Neither genotype nor a genotype–drug interaction significantly affected the results (all p > 0.7). The study provides evidence that ketamine has short-term effects on hippocampal subfield volumes in humans. The results translate previous findings from animal models of depression showing that ketamine has pro-neuroplastic effects on hippocampal structures and underscore the importance of the hippocampus as a key region in ketamine’s mechanism of action. |
url |
https://doi.org/10.1038/s41398-021-01318-6 |
work_keys_str_mv |
AT annahoflich translatingtheimmediateeffectsofsketamineusinghippocampalsubfieldanalysisinhealthysubjectsresultsofarandomizedcontrolledtrial AT christophkraus translatingtheimmediateeffectsofsketamineusinghippocampalsubfieldanalysisinhealthysubjectsresultsofarandomizedcontrolledtrial AT ruthmpfeiffer translatingtheimmediateeffectsofsketamineusinghippocampalsubfieldanalysisinhealthysubjectsresultsofarandomizedcontrolledtrial AT reneseiger translatingtheimmediateeffectsofsketamineusinghippocampalsubfieldanalysisinhealthysubjectsresultsofarandomizedcontrolledtrial AT danrujescu translatingtheimmediateeffectsofsketamineusinghippocampalsubfieldanalysisinhealthysubjectsresultsofarandomizedcontrolledtrial AT carlosazarate translatingtheimmediateeffectsofsketamineusinghippocampalsubfieldanalysisinhealthysubjectsresultsofarandomizedcontrolledtrial AT siegfriedkasper translatingtheimmediateeffectsofsketamineusinghippocampalsubfieldanalysisinhealthysubjectsresultsofarandomizedcontrolledtrial AT dietmarwinkler translatingtheimmediateeffectsofsketamineusinghippocampalsubfieldanalysisinhealthysubjectsresultsofarandomizedcontrolledtrial AT rupertlanzenberger translatingtheimmediateeffectsofsketamineusinghippocampalsubfieldanalysisinhealthysubjectsresultsofarandomizedcontrolledtrial |
_version_ |
1721542427374780416 |